HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 26, 1999, Pages 15109-15114

  Davey Jr , Richard T ^a,b   Bhat, Niranjan ^a   Yoder, Christian ^b   Chun, Tae Wook ^a   Metcalf, Julia A ^a   Dewar, Robin ^c   Natarajan, Ven ^c   Lempicki, Richard A ^c   Adelsberger, Joseph W ^c   Miller, Kirk D ^b   Kovacs, Joseph A ^b   Polis, Michael A ^a   Walker, Robert E ^a   Falloon, Judith ^a   Masur, Henry ^b   Gee, Dennis ^d   Baseler, Michael ^c   Dimitrov, Dimiter S ^d   Fauci, Anthony S ^a   Lane, H Clifford ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antiretroviral drugs; CD4; HIV 1 infection; Relapse; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; INDINAVIR; INTERLEUKIN 2; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RECURRENT DISEASE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; DRUG THERAPY, COMBINATION; FORECASTING; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; LYMPH NODES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033592967     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.26.15109     Document Type: Article

References (31)